Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nr-CWS for persistent high-risk HPV cervical infection
ChiCTR2100050129Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in human papillomavirus infection and cervical intraepithelial neoplasia (CIN) comparing Nr-CWS topical treatment with Topical placebo (2 arms). Primary endpoints: HPV DNA typing test and HPV negative conversion rate. Started Aug 2017; status: recruiting.
02
Drugs
nocardia rubra cell wall skeleton
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on ChiCTR2100050129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050129.